A better Alzheimer’s drug?
A long trek nears its destination
Drug Development
On the cusp
Closing in on medical solutions — from preventing kidney stones to stopping Alzheimer’s and curing ovarian cancer
A heart-protective mutation in a pill
Genetic insights lead to a new treatment for cardiomyopathy
Catalyst
How a rigorous framework is spurring medical solutions
Stopping kidney stones at the source
A Stanford Medicine nephrologist is developing drugs that could prevent kidney stones
Game on
Crowdsourced molecular computers open a path toward a better TB test
Innovation in bloom
How curiosity, collaboration and public funding grew into a lifesaving therapy
An ointment to quell atopic dermatitis
Quieting the intense itch of a common skin condition
Why is a common gene variant bad for your brain?
The answer offers clues for a new kind of Alzheimer’s drug
Clinical trials in a dish
Fast-forwarding drug development